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The aim of this study was to evaluate the effects of caffeine on physiological responses to
submaximal exercise, with a focus on blood lactate concentration ([BLa]).
Methods
Using a randomised, single-blind, crossover design; 16 endurance-trained, male cyclists
(age: 38 ± 8 years; height: 1.80 ± 0.05 m; body mass: 76.6 ± 7.8 kg; _VO2max: 4.3 ± 0.6 Lmin-
1) completed four trials on an electromagnetically-braked cycle ergometer. Each trial con-
sisted of a six-stage incremental test (3 minute stages) followed by 30 minutes of passive
recovery. One hour before trials 2–4, participants ingested a capsule containing 5 mgkg-1
of either caffeine or placebo (maltodextrin). Trials 2 and 3 were designed to evaluate the
effects of caffeine on various physiological responses during exercise and recovery. In con-
trast, Trial 4 was designed to evaluate the effects of caffeine on [BLa] during passive recov-
ery from an end-exercise concentration of 4 mmolL-1.
Results
Relative to placebo, caffeine increased [BLa] during exercise, independent of exercise
intensity (mean difference: 0.33 ± 0.41 mmolL-1; 95% likely range: 0.11 to 0.55 mmolL-1),
but did not affect the time-course of [BLa] during recovery (p = 0.604). Caffeine reduced rat-
ings of perceived exertion (mean difference: 0.5 ± 0.7; 95% likely range: 0.1 to 0.9) and
heart rate (mean difference: 3.6 ± 4.2 bmin-1; 95% likely range: 1.3 to 5.8 bmin-1) during
exercise, with the effect on the latter dissipating as exercise intensity increased. Supple-
ment × exercise intensity interactions were observed for respiratory exchange ratio (p =
0.004) and minute ventilation (p = 0.034).
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Conclusions
The results of the present study illustrate the clear, though often subtle, effects of caffeine
on physiological responses to submaximal exercise. Researchers should be aware of these
responses, particularly when evaluating the physiological effects of various experimental
interventions.
Introduction
Caffeine, a trimethylxanthine, is one of the most commonly consumed drugs in the world, with
no apparent long-term adverse health effects [1]. Research into the ergogenic properties of caf-
feine has revealed benefits across a range of exercise intensities and durations, with the greatest
effects being displayed in sustained high-intensity aerobic activities [2,3]. Indeed, typical doses
of 3–6 mgkg-1 ingested 30–90 minutes prior to exercise have produced positive effects (0.7–
5.4%) in time trial events lasting 5–60 minutes [4–15]. Nevertheless, the mechanisms to explain
the beneficial effects of caffeine supplementation on exercise performance remain unresolved.
Although early research supported a glycogen-sparing mechanism of action, the absence of a
corroborative change in respiratory exchange ratio (RER), combined with evidence of signifi-
cant effects in relatively short events (< 60 minutes) where glycogen availability would not be a
limiting factor [3], has led researchers to consider alternative explanations. At present,
although the lipophilic properties of caffeine leave room for a possible small direct intracellular
effect on muscle function [16], the key mechanism by which caffeine is believed to enhance
sustained high-intensity performance is via a central mechanism involving the antagonism of
adenosine receptors and leading to increases in neurotransmitter release, motor unit firing
rates, and pain suppression [17].
Most studies have attempted to explain the beneficial effects of caffeine supplementation on
sustained high-intensity exercise by evaluating corresponding changes in various physiological
responses such as heart rate, blood lactate [BLa], oxygen uptake ( _VO2), RER, etc. However,
since most of those studies have observed a caffeine-induced improvement in exercise perfor-
mance, it is difﬁcult to distinguish the direct effects of caffeine on physiological responses from
those associated with the improved performance. Although several studies have attempted to
address this problem by including a ﬁxed-intensity submaximal bout of exercise (generally at
around 60–80% _VO2max) prior to a performance-based test, and often as part of a warm-up, the
results contain some discrepancies. For example, whilst some studies have found no effect of
caffeine on minute ventilation ( _VE) [18–20], others have reported a signiﬁcant increase [4,7].
Similarly, many studies report no effect of caffeine on _VO2 [4,5,7,9,13,14,18,20–23], though
some have reported a signiﬁcant increase [5,15].
One particularly strange effect that often accompanies caffeine supplementation, and
thereby providing further evidence against a glycogen-sparing mechanism of action, is an ele-
vation in [BLa] during exercise (3). The effect is strange because, although the increase in [BLa]
can often be explained by a concomitant caffeine-induced increase in performance [5–8,11,
13,14,22], this is not always the case [24]. Moreover, while some studies have found no effect of
caffeine supplementation on [BLa] during submaximal exercise [4,13–15,18–20,25,26], others
have observed a significant increase [5,9,21,22]. To complicate matters further, Graham et al.
[21] could not attribute the caffeine-induced increase in [BLa] during submaximal exercise to
an increase in production or release by the active muscles. In effect, this leaves four possibilities;
first, that the methods used by Graham et al. [21], though more complex than most, lacked
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sufficient sensitivity to detect changes in muscle lactate production and release resulting from
caffeine supplementation; secondly, that lactate is being produced from inactive muscle;
thirdly, that caffeine impairs [BLa] clearance; and finally, that those studies finding a caffeine-
induced increase in [BLa] were, in some way, affected by methodological limitations (i.e. lim-
ited sample size, or a failure to control cadence). Of those possibilities, the idea that the caf-
feine-induced increase in [BLa] could be due to an impairment of lactate clearance is plausible,
given that gluconeogenesis accounts for 20–30% of lactate clearance during exercise [27], and
that adenosine signalling has been shown to stimulate gluconeogenesis, at least in animal mod-
els [28]. Nevertheless, the ubiquitous nature of adenosine receptors coupled with their ability
to activate and inhibit the same signalling cascades [28] makes it difficult to identify the precise
mechanism by which caffeine influences [BLa]. The aims of the present study, therefore, were
to evaluate the effects of caffeine supplementation on physiological responses to submaximal
exercise, with a particular focus on the effects on [BLa]. It was hypothesised that caffeine would
increase [BLa] during exercise and slow its rate of clearance during recovery.
Materials and Methods
Participants
Sixteen endurance-trained [29], competitive, male athletes (cyclists and triathletes) volunteered
for the study which was approved by St Mary’s University Ethics Committee. Prior to testing,
participants received written and verbal instructions regarding the nature of the investigation
and completed a training history questionnaire, which indicated that all had been actively
involved in sport for approximately 19 ± 10 years and that, at the time of the investigation, the
distance cycled each week was 211 ± 65 km. Prior to commencement, all participants completed
a health-screening questionnaire and provided written informed consent. Means ± standard
deviation for age, height, body mass, body fat, and _VO2max of the participants were: 38 ± 8 years,
1.80 ± 0.05 m, 76.6 ± 7.8 kg; 17.5 ± 3.5%, and 4.3 ± 0.6 Lmin-1 (55.6 ± 5.0 mlkg-1min-1), respec-
tively. Participants were instructed to maintain their normal diet throughout the testing period,
to follow the same diet for 24 hours prior to each trial, to avoid food and drink in the hour before
each trial, and to refrain from strenuous exercise for 24 hours before each trial. Participants were
provided with a list of dietary sources of caffeine and asked to refrain from consuming these for
24 hours prior to each trial. A questionnaire was used to establish normal daily caffeine intake.
Procedures
All trials were completed at approximately the same time of day in a laboratory which was ther-
mostatically controlled at 19°C. On arrival at the laboratory, and after approximately five min-
utes of seated rest, a resting blood sample (~ 5 ml) was drawn from a branch of the basilic vein
and collected in a lithium-heparin tube (Vacutainer; Becton Dickinson, Oxford, United King-
dom). At the same time, a blood sample was obtained from the earlobe via capillary puncture
for the evaluation of [BLa] via an automated analyser (Biosen C-Line; EKF Diagnostic, Eben-
dorfer Chaussee, Barleben, Germany). In Trial 1, participants subsequently had their body fat
content evaluated using a four-site skinfold protocol [30], before completing a submaximal
incremental step test on an electromagnetically-braked cycle ergometer (Lode Excalibur Sport;
Groningen, Holland). The cycle ergometer was fitted with clipless pedals and participants
cycled using their own cycling shoes. Prior to Trial 1, the ergometer was adjusted (saddle height
and handlebar position) for each participant and the settings were noted for replication in trials
2–4. The starting intensity and increment size for each participant for Trial 1 was estimated,
based upon feedback from participants regarding their typical race pace, to achieve a [BLa]
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profile consisting of 5–8 stages beginning at a [BLa] of around 1 mmolL-1 and ending with a
[BLa]> 4 mmolL-1. The duration of each increment was 3 minutes, and a 30 s break was pro-
vided at the end of each stage to enable [BLa] to be evaluated. To limit any effect of cadence on
the [BLa] response to exercise [31], participants were given 30 s during the first stage of Trial 1
to achieve a comfortable cadence and were instructed to maintain this throughout all trials.
Heart rate was monitored at 5 s intervals throughout all trials using a heart rate monitor (Polar
s610i; Polar Electro Oy, Kempele, Finland), and ratings of perceived exertion (RPE) were
recorded 30 s from the end of each incremental stage using a 15-point scale [32]. After five
minutes of passive rest, participants completed a second incremental test (Trial 1 only), using
the same starting intensity and increment size; however, for this phase of the trial the duration
of each increment was reduced to 1 minute. The test was terminated when participants reached
volitional exhaustion, at which time a final [BLa] measurement was obtained. Oxygen uptake
was monitored (breath-by-breath) throughout all trials using an on-line gas analyser (Oxycon
Pro; Jaeger, Hoechberg, Germany). The analyser was calibrated before each trial using oxygen
and carbon dioxide gases of known concentrations (Cryoservice; Worcester, UK) and the flow-
meter was calibrated using a 3-litre syringe (Viasys Healthcare GmbH; Hoechberg, Germany).
During all trials participants breathed room air through a facemask (Hans Rudolph; Kansas
City, MO, USA) that was secured in place by a head-cap assembly (Hans Rudolph; Kansas
City, MO, USA). _VO2max was determined as the highest 30 s average _VO2 recorded during the
second incremental test of Trial 1 provided that at least two of the following criteria had been
met: 1) A plateau in _VO2; as determined by an increase of less than 2 mlkg-1min-1 over the
previous stage; 2) A RER 1.15; 3) A heart rate within 10 bmin-1 of age predicted maximum;
4) A [BLa] 8 mmolL-1.
In trials 2–4, after the first venous blood sample was obtained, participants ingested a gela-
tine capsule containing either 5 mgkg-1 of caffeine (My Protein; Manchester, UK), or placebo
(maltodextrin: My Protein; Manchester, UK). After supplementation, participants rested for 40
minutes before the same blood sampling procedure was repeated. In trials 2 and 3, using a single-
blind balanced randomised crossover design, participants completed subsequently a six-stage
submaximal incremental test with Stage 3 set at the power output required to elicit the gas
exchange threshold (GET) and Stage 6 set at the power output required to elicit the onset of [Bla]
accumulation (OBLA); the latter equating to a [Bla] of 4 mmolL-1 [33]. The GET was estimated
from visual inspection of the _VCO2  _VO2 relationship, established in Trial 1, using the V
−slope method [34]. OBLA was identiﬁed using software (Lactate-E) speciﬁcally developed for
the purpose [35]. Prior to start of each incremental test, participants sat passively on the cycle
ergometer for 3 minutes to enable resting measures (determined from the ﬁnal 30 s) of _VO2,
RER, _VE, breathing frequency (BF), and heart rate to be recorded. Upon completion of each
incremental test, participants rested passively for 30 minutes. As in Trial 1, [BLa] was evaluated
at the end of every incremental stage, but also at 2 minute intervals during recovery. _VO2, RER,
_VE, BF, heart rate, and RPE were monitored throughout all incremental tests and during recov-
ery. Respiratory data were ﬁltered by removing values (attributed to noise) that were outside
three standard deviations of the local mean, linearly interpolated to provide values at 1 s intervals,
and averaged over the ﬁnal 30 s of each incremental stage to provide a mean response for each
exercise intensity. Respiratory data were also averaged over the ﬁnal 30 s of each post-exercise
recovery period to determine whether any effects of caffeine at rest returned during recovery.
The step incremental protocol for Trial 4 was determined by evaluating which of trials 2
and 3 produced an end-exercise [BLa] closest to 4 mmolL-1. If the answer was the placebo
trial, then caffeine was administered as the supplement in Trial 4, and the results of the previ-
ous caffeine supplemented trial were used to adjust the protocol (again evaluated using the
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Lactate-E software) to achieve an end-exercise [BLa] close to 4 mmolL-1. If, on the other hand,
caffeine produced the end-exercise [BLa] closest to 4 mmolL-1 then Trial 4 became a placebo
supplemented trial, with the protocol adjusted accordingly based on the results of the previous
placebo trial. In effect, Trial 4 was designed to evaluate the effects of caffeine on [BLa] clearance
during passive recovery from a fixed starting [BLa] of approximately 4 mmolL-1. The recovery
kinetics of [BLa] were evaluated by fitting mono-exponential models (Eq 1) to the data, using a
non-linear least-squares fitting procedure (XLfit, IDBS Ltd, Guildford, UK). The data were
modelled from 2 minutes into the recovery process to allow for any muscle to sampling site
time delay.
½BLaðtÞ ¼ Dþ ðA expððð1Þ  ð1=tÞÞ  tÞÞ Eqn 1
Where [BLa](t) is the lactate concentration at time t; D is the amplitude of the ﬁtted model; A
is the initial value of [BLa] minus D; and τ is the time constant of the response.
Venous blood samples were centrifuged at 3000 rpm for 10 minutes, with subsequently
decanted plasma samples frozen at -80°C until analysed for caffeine content using high-perfor-
mance liquid chromatography (HPLC). Before analysis, plasma samples were thawed, trans-
ferred to a separating flask, and made up to 2 mL with HPLC grade water. Following the
addition of an internal standard, samples underwent solvent extraction using a chloroform/
IPA mix (85%/15%). Each sample was extracted twice and the organic phase was removed
each time. The organic phase from both extracts were subsequently combined, evaporated to
dryness under nitrogen, and re-suspended in HPLC grade water. Analysis of caffeine content
was carried out by reverse phase HPLC using a C18 column (Zorbax Eclipse Plus, Agilent
Technologies Ltd., Stockport, UK) with a mobile phase of 80% water/20% methanol, a flow
rate of 1.5 mLmin-1, and ultra-violet detection at 274 nm.
Statistical Analysis
All statistical analyses were conducted using the Statistical Package for the Social Sciences (SPSS
for Windows; IBM Corporation, Armonk, New York, USA). Measures of centrality and spread
are presented as means ± standard deviation. Differences between plasma samples in caffeine
content were evaluated using a one-way repeated measures analysis of variance (ANOVA). The
effects of caffeine supplementation on resting measures of [BLa] were evaluated using a two-way
(supplement × time) repeated measures ANOVA; with effects on the other physiological mea-
sures, at rest and during the last 30 s of recovery, determined using paired-samples t-tests. The
effects of supplementation on the time constants of the exponential models used to describe the
recovery kinetics of [BLa] were also determined using a paired-samples t-test. Goodness of fit of
the exponential models was evaluated using F tests. The effects of caffeine on physiological
responses during the incremental tests, including the effects on [BLa] during recovery, were eval-
uated using two-way (supplement × exercise intensity or time) ANOVAs with repeated measures
on both factors. α was set at 0.05 for all analyses. Violations to assumptions of sphericity were
adjusted using the Greenhouse-Geisser correction factor. Significant interactions were followed-
up using post hoc tests with Bonferroni adjustments for multiple comparisons. The above analy-
ses provided 95% confidence limits for all estimates.
Results
Caffeine Consumption
Mean habitual caffeine consumption of the participants was estimated as 225 ± 135 mgd-1.
Subject compliance with caffeine restriction prior to each trial was confirmed by the fact that in
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all non-caffeine supplemented conditions, plasma caffeine concentrations were low
(0.25 ± 0.28 μgmL-1), whereas values were high (3.90 ± 2.23 μgmL-1) following caffeine.
Blood Lactate
Blood lactate concentration decreased significantly (F(1,15) = 15.87; p< 0.001) (mean difference:
0.20 ± 0.19 mmolL-1; 95% likely range: 0.11 to 0.29 mmolL-1) from pre-supplementation values
of 1.24 ± 0.37 and 1.12 ± 0.40 mmolL-1 for caffeine and placebo trials respectively, to correspond-
ing post-supplementation (pre-exercise) values of 1.07 ± 0.41 and 0.90 ± 0.34 mmolL-1. However,
there was no effect of supplementation (F(1,15) = 1.30; p = 0.263) and no supplement × time inter-
action (F(1,15) = 0.25; p = 0.624). The effects of caffeine on [BLa] during exercise and recovery
are presented in Fig 1. Relative to placebo, caffeine led to a significant increase (F(1,15) = 10.13;
p = 0.006) in [BLa] throughout the incremental tests of 0.33 ± 0.41 mmolL-1 (95% likely range:
0.11 to 0.55 mmolL-1); and there was a significant effect of exercise intensity on [BLa] (F(1.3,19.6) =
181.57; p< 0.001). However, there was no significant supplement × exercise intensity interaction
(F(1.6,23.9) = 0.72; p = 0.466). In contrast, [BLa] decreased significantly over time during recovery
(F(1.6,23.4) = 213.28; p< 0.001), but there was no effect of supplementation on the recovery process
(F(1,15) = 0.28; p = 0.604), and no supplement × time interaction (F(2.6,39.1) = 1.74; p = 0.181). The
recovery kinetics of [BLa] were very well described by the mono-exponential models (mean F-test
scores: caffeine = 1.010 ± 0.008; placebo = 1.013 ± 0.006); however, time constants were not signif-
icantly different (t(15) = 0.53; p = 0.604) between the caffeine (τ = 14.8 ± 6.7 minutes) and the pla-
cebo (τ = 14.3 ± 6.0 minutes) conditions.
Heart Rate
The effects of caffeine supplementation on resting values of heart rate, _VO2, RER, _VE, and
BF are presented in Table 1. Relative to placebo, caffeine supplementation led to a signiﬁcant
(t(15) = 3.36; p = 0.004) reduction in heart rate at rest (mean difference: 3.6 ± 4.2 bmin-1; 95%
likely range: 1.3 to 5.8 bmin-1) and during incremental exercise (F(1,15) = 14.49; p = 0.002).
However, the effect of caffeine on heart rate dissipated as exercise intensity increased
Fig 1. The effects of caffeine supplementation on blood lactate concentration during submaximal incremental exercise (A); and in recovery from
submaximal incremental exercise designed to achieve an end-exercise blood lactate concentration of 4 mmolL-1 (B). Values are means; bars are
standard deviations. GET = Gas exchange threshold; OBLA = Onset of blood lactate accumulation. † = significant main effect of supplement.
doi:10.1371/journal.pone.0161375.g001
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(interaction effect: F(5,75) = 2.49; p = 0.039). Post hoc tests revealed signiﬁcant reductions in
heart rate during the ﬁrst three incremental stages only (Fig 2A). The effects of caffeine on the
recovery of heart rate, _VO2, RER, and _VE following the incremental tests in trials 2 and 3
are presented in Fig 3. After 30 minutes of recovery, heart rate was not signiﬁcantly different
(t(15) = 0.88; p = 0.391) between caffeine and placebo conditions (Table 2).
Ratings of Perceived Exertion
Perceived exertion increased progressively during the incremental tests (F(1.3,20.1) = 167.84;
p< 0.001), and RPE was significantly lower (F(1,15) = 8.81; p = 0.010) following caffeine supple-
mentation than following placebo (mean difference: 0.5 ± 0.7; 95% likely range: 0.1 to 0.9).
However, there was no supplement × exercise intensity interaction (F(2.1,32.1) = 0.77; p = 0.48)
(Fig 2B).
Oxygen Uptake
There was a significant effect of exercise intensity on _VO2 (F(1.5,21.9) = 305.54; p< 0.001) and,
in comparison with placebo, caffeine supplementation signiﬁcantly increased (t(15) = 2.51;
p = 0.024) _VO2 at rest (mean difference: 0.06 ± 0.09 Lmin-1; 95% likely range: 0.01 to 0.11
Lmin-1; Table 1) and at the end of 30 minutes of post-exercise passive recovery (mean difference:
0.07 ± 0.07 Lmin-1; 95% likely range: 0.03 to 0.11 Lmin-1; Table 2). However, relative to placebo,
there was no signiﬁcant effect of caffeine on _VO2 during the incremental tests (F(1,15) = 3.49;
p = 0.082) (mean difference: 0.06 ± 0.12 Lmin-1; 95% likely range: -0.01 to 0.12 Lmin-1), and no
supplement × exercise intensity interaction (F(5,75) = 0.879; p = 0.499) (Fig 4A).
Respiratory Exchange Ratio
Respiratory exchange ratio increased significantly during the incremental tests (F(2.1,31.0) =
161.98; p< 0.001) and, in comparison with placebo, caffeine significantly increased (t(15) =
2.25; p = 0.040) RER at rest (mean difference: 0.04 ± 0.06; 95% likely range: 0.001 to 0.07;
Table 1). However, whilst there was no main effect of supplement during the incremental test
(F(1,15) = 2.17; p = 0.162), there was a significant supplement × exercise intensity interaction
(F(2.9,43.4) = 5.24; p = 0.004) (Fig 4B). Nevertheless, post hoc tests were unable to identify where
those differences were. Moreover, relative to placebo, there was no significant effect (t(15) =
1.23; p = 0.240) of caffeine on RER at the end of the post-exercise recovery period (Table 2).
Minute Ventilation
Minute ventilation increased progressively during the incremental tests (F(1.2,18.5) = 186.30;
p< 0.001), and, in comparison with placebo, there was a significant increase (t(15) = 2.44;
p = 0.027) in _VE at rest (mean difference: 1.9 ± 3.1 Lmin-1; 95% likely range: 0.2 to 3.6 Lmin-1;
Table 1. The effects of caffeine supplementation on restingmeasures of heart rate, oxygen uptake, respiratory exchange ratio, minute ventilation,
and breathing frequency. Values are means ± standard deviations.
Supplement Heart rate (bmin-1) Oxygen uptake (Lmin-1) RER Minute ventilation (Lmin-1) Breathing frequency (breathsmin-1)
Caffeine 59.5 ± 8.1* 0.45 ± 0.10* 0.84 ± 0.10* 14.21 ± 2.93* 14.4 ± 4.1
Placebo 63.0 ± 7.8 0.39 ± 0.08 0.81 ± 0.10 12.31 ± 3.55 14.6 ± 5.4
Note: RER = Respiratory exchange ratio.
* signiﬁcantly different (p < 0.05) from placebo.
doi:10.1371/journal.pone.0161375.t001
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Table 1), though not during exercise (F(1,15) = 0.39; p = 0.543), following caffeine supplementa-
tion. Although there was a signiﬁcant supplement × exercise intensity interaction (F(2.6,39.2) =
3.36; p = 0.034) (Fig 4C), post hoc tests were unable to identify where those differences were.
Nevertheless, relative to placebo, caffeine signiﬁcantly increased _VE (t(15) = 2.93; p = 0.011) at
the end of the post-exercise recovery period (mean difference: 1.8 ± 2.4 Lmin-1; 95% likely
range: 0.5 to 3.1 Lmin-1; Table 2).
Breathing Frequency
Breathing frequency increased progressively throughout the incremental tests (F(1.9,28.5) =
65.53; p< 0.001) from starting values (grand means) of 23.9 ± 3.4 breathsmin-1 to end-exer-
cise values of 32.8 ± 5.3 breathsmin-1; however, relative to placebo, there was no effect of caf-
feine supplementation on BF either at rest (mean difference: 0.2 ± 4.1 breathsmin-1; 95% likely
range: -2.0 to 2.3 breathsmin-1; Table 1) or during the incremental tests (F(1,15) = 0.79;
p = 0.387). Similarly, there was no supplement × exercise intensity interaction (F(5,75) = 1.67;
p = 0.152).
Discussion
The aims of the present study were to evaluate the effects of caffeine supplementation on physi-
ological responses to submaximal exercise, with a particular focus on the effects on [BLa]. The
key findings were that relative to placebo, caffeine significantly increased [BLa] during exercise,
but, when matched for the same end-exercise concentration, did not affect the rate of clearance
in recovery. Moreover, there were significant effects on heart rate, RPE, and various respiratory
measures, adding support to potential multifactorial whole-body effects of caffeine.
The significant effects of caffeine on [BLa] during incremental exercise were independent of
exercise intensity. Given the absence of any effect of caffeine on [BLa] at rest, it appears that
some degree of mechanical stress is required to achieve the response. As such, it seems unlikely
that the caffeine-induced elevations in [BLa] can be attributed to an increased contribution
from muscles that are not recruited during the exercise. Moreover, the absence of any effect of
Fig 2. The effects of caffeine supplementation on heart rate (A) and ratings of perceived exertion (B) during submaximal incremental exercise.
Values are means; bars are standard deviations. GET = Gas exchange threshold; OBLA = Onset of blood lactate accumulation. † = significant main effect
of supplement; * = significant differences (p < 0.05) at the same exercise intensity.
doi:10.1371/journal.pone.0161375.g002
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caffeine on the rate of [BLa] clearance in recovery suggests that the elevation in [BLa] was most
likely due to an increase in lactate efflux from the working muscles, and thereby supportive of a
caffeine-stimulated increase in glycolysis. While this suggestion conflicts with the findings of
Graham et al. [21], at this point it is worth noting that in the present study, the effects of caf-
feine on [BLa] during exercise, though significant, were relatively small. As such, it is possible
that the techniques used by Graham et al. [21] may have lacked sufficient sensitivity to detect
changes of the magnitude indicated by the present study. Then again, in a study which
Fig 3. The effects of caffeine supplementation on heart rate (A), oxygen uptake (B), respiratory exchange ratio (C), and minute ventilation (D) measured at 5
s intervals during recovery from a bout of submaximal incremental exercise. Values are means.
doi:10.1371/journal.pone.0161375.g003
Table 2. The effects of caffeine supplementation onmeasures of blood lactate, heart rate, oxygen uptake, respiratory exchange ratio, andminute
ventilation in the final 30 s of a 30 minute recovery period following submaximal incremental exercise. Values are means ± standard deviations.
Supplement Blood lactate (mmolL-1) Heart rate (bmin-1) Oxygen uptake (Lmin-1) RER Minute ventilation (Lmin-1)
Caffeine 1.38 ± 0.45 70.8 ± 9.0 0.43 ± 0.07* 0.82 ± 0.05 15.16 ± 2.21*
Placebo 1.27 ± 0.41 72.2 ± 10.5 0.36 ± 0.08 0.80 ± 0.04 13.35 ± 2.62
Note: RER = Respiratory exchange ratio.
* signiﬁcantly different (p < 0.05) from placebo.
doi:10.1371/journal.pone.0161375.t002
Caffeine and Submaximal Exercise
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combined the effects of a number of small sample size investigations, Graham et al. [36] found
no difference between caffeine and placebo treatments on post-exercise (70–85% _VO2max) mus-
cle glycogen concentrations. Given the relatively short duration of the exercise bouts (10–15
minutes) and the typical variability (~ 10%) in single muscle biopsy glycogen measurements
[37], the effects of caffeine on glycogen depletion and lactate release in active muscle is clearly
an area worthy of further investigation. Nevertheless, small changes in [BLa] coupled with the
use of relatively small sample sizes may help to explain why signiﬁcant effects of caffeine on
[BLa] during submaximal exercise have been observed in some investigations [5,9,21,22], but
not in others [4,13–15,18–20,25,26]; particularly given the fact that apart from Tarnopolsky
et al. [20] andWiles et al. [15], all of the latter reported a higher mean [BLa] response with
caffeine.
Although the results of the present study support a positive effect of caffeine on glycolysis in
active muscle during exercise, the mechanisms to explain that response are unclear [36]. At
present, if true, the response seems most likely to be due to a direct effect on skeletal muscle via
an antagonism of A1 adenosine receptors [36], and leading to a corresponding increase in
intracellular cyclic adenosine monophosphate. Regardless of the mechanism, the response con-
flicts with any notion that caffeine has a glycogen-sparing mode of action. Then again, the idea
of a caffeine-induced increase in glycolysis is difficult to reconcile with the absence, as in many
previous studies [4,5,7,13,14,18,20–23,25], of a corresponding reduction in _VO2. Indeed, caf-
feine led to a signiﬁcant increase in _VO2 at rest and at the end of recovery. In effect, these ﬁnd-
ings suggest that either caffeine is increasing energy metabolism irrespective of energy
demand, or that caffeine is somehow causing a reduction in exercise efﬁciency. Given the estab-
lished beneﬁts of caffeine on aerobic-endurance based activities [1,2,3], the latter seems highly
unlikely. In contrast, the idea of an increase in energy turnover forms part of the rationale for
those studies that have investigated potential debilitative effects of caffeine on exercise toler-
ance in hot environments [38–42]. Despite a couple of exceptions [38,39], and a recurring
theme of poor sample sizes and issues with experimental design [40]; there is little evidence of
any caffeine-induced increases in metabolic rate or core temperature under those conditions
[40–42]. Then again, and in contrast to the general consensus, those same studies have also
mostly reported no effect of caffeine on sustained high-intensity aerobic exercise [38–40].
Although the effects of caffeine on [BLa] in the present study could be explained by a corre-
sponding increase in glycolysis, it is difficult to reconcile that response with the pattern
observed in RER. First, the significant caffeine-induced increase in resting measures of RER
and _VO2, despite no change in [BLa], suggests a disproportionate corresponding increase in
_VCO2. Secondly, the interaction between supplement and exercise intensity on RER suggests
that the effect of caffeine on resting RER reversed as exercise intensity increased. Although post
hoc tests were unable to locate signiﬁcant differences resulting from the supplement × intensity
interaction, a similar pattern of response in RER was observed by Stadheim et al. [13] across
four ﬁxed-intensity submaximal exercise bouts (40–70% _VO2max), with a signiﬁcant effect
being observed at the highest intensity. Moreover, although most previous research has failed
to ﬁnd an effect of caffeine on RER during single bouts of submaximal exercise
[4,5,7,15,20,21,23,25], the trend, as in the present study, is towards a negative effect of caffeine
on RER during exercise at moderate to high intensities [4,5,7,13,15,19–21,25]. Nevertheless,
the result is at odds with the fact that increases in [BLa] are typically associated with increases
Fig 4. The effects of caffeine supplementation on oxygen uptake (A), respiratory exchange ratio (B),
andminute ventilation (C) during submaximal incremental exercise. Values are means; bars are
standard deviations. GET = Gas exchange threshold; OBLA = Onset of blood lactate accumulation.
doi:10.1371/journal.pone.0161375.g004
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in RER, particularly as submaximal exercise intensity increases [43]. Moreover, and in contrast
to the effect at rest, the absence of a signiﬁcant effect of caffeine on _VO2 suggests that the effect
on RER was due to a disproportionate reduction in _VCO2 as exercise intensity increased.
It is difficult to resolve the mechanisms by which caffeine influenced the interaction effect
on RER; however, it is possible that the effect was, at least in part, mediated by the correspond-
ing supplementation × intensity interaction on _VE. Previous research into the effects of caffeine
on _VE during submaximal exercise has reported either a signiﬁcant increase [4,7] or no effect
[18–20]. In the present study, caffeine increased _VE at rest and, despite the absence of signiﬁ-
cant post hoc tests, the effect appeared to dissipate as exercise intensity increased. Moreover,
the effect at rest returned in recovery. Given that effects were independent of any change in BF,
changes in _VE appear to be largely the result of changes in tidal volume. The stimulatory effect
of caffeine on _VE at rest has previously been observed in primates [44] and is attributed to a
lowering of the sensitivity threshold for CO2 of central chemoreceptors; likely mediated by
antagonism of adenosine receptors or, though less likely [17], by phosphodiesterase inhibition
[44]. A caffeine-induced increase in _VE at rest would result in an increase in _VCO2 and as such
help to explain the corresponding increase in RER. Then again, it is difﬁcult to reconcile that
mechanism with the ﬁndings of McClaran &Wetter [45], who observed a signiﬁcant reduction
in RER at rest, albeit with a lower caffeine dose (3 mgkg-1), with no corresponding change in
_VE, or _VO2. Moreover, in the present study, although the effect of caffeine on _VE showed signs
of dissipating as exercise intensity increased (interaction effect), it is difﬁcult to speculate as to
how this response could explain the supplement × exercise intensity interaction on RER.
The caffeine-induced reduction in resting heart rate observed in the present study is of a
magnitude similar to that previously reported [46]. Moreover, the response adds support to the
idea that the effects of caffeine are mediated most likely by the antagonism of adenosine recep-
tors, since adenosine infusion has been shown to increase resting heart rate by reducing para-
sympathetic and increasing sympathetic nervous system outflow [47]. Although the effect of
caffeine on heart rate at rest did not return during recovery; given the pattern of the response
(Fig 3A) and the fact that post-exercise heart rate did not return to pre-exercise resting values
by the end of the 30 minute recovery period, it is possible that the effect would have returned if
the recovery period had been extended. In contrast, the dissipation of the effect of caffeine on
heart rate as exercise intensity increased was not anticipated, but provides an explanation as to
why previous research, using continuous bouts of submaximal exercise at intensities similar to
those at the upper end of the profile used in the present study, have failed to find an effect of
caffeine on heart rate [4,5,7,9,11,13,14,18,20–23,25]. Indeed, the results of the present study
suggest that the caffeine-induced elevations in heart rate that have been observed in some per-
formance-based studies are likely to be due to the correspondingly higher exercise intensities
maintained by the participants rather than from any direct stimulatory effect of caffeine
[6,8,11,13,14].
Although the effects of caffeine on heart rate dissipated as exercise intensity increased, RPE
was suppressed by caffeine throughout the incremental protocol. Given that the RPE scale was
developed to reflect heart rate responses to exercise [29], the results of the present study suggest
that caffeine may have some effect on the stability of that relationship. Nevertheless, the results
of the present study confirm previous reports of a suppressive effect of caffeine on RPE during
constant-load submaximal exercise [48]; an effect that is likely to be due to the antinociceptive
effects of caffeine, mediated centrally by antagonism of A1 adenosine receptors [17]. Indeed,
the antinociceptive effects of caffeine may explain many, if not all, of the subsequent perfor-
mance enhancing effects [16,48].
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Conclusion
Despite many years of research, the effects of caffeine supplementation on physiological
responses to exercise remain unresolved, most likely because of issues associated with small
sample sizes and the associated risks of type 2 statistical errors. Moreover, the complex central
and peripheral effects of caffeine, which appear to be associated predominantly with the antag-
onism of the various adenosine receptors subtypes, make it difficult to discern mechanisms of
action. Nevertheless, the results of the present study support a caffeine-induced increase in
[BLa] during exercise; an effect which appears to be independent of exercise intensity and
which, though easily explained by a stimulation of glycolysis, clearly requires more research to
clarify. In addition, caffeine reduced resting heart rate and increased resting _VO2, RER, and
_VE. Although the effects of caffeine on heart rate, RER and _VE, were inﬂuenced additionally
and differentially by exercise intensity, it is difﬁcult to discern if any of these effects are respon-
sible for the ergogenic action of caffeine. Finally, caffeine reduced RPE during exercise, again
independently of exercise intensity, and this effect remains one of the key factors which may
explain the beneﬁt of caffeine on sustained high-intensity aerobic exercise.
Acknowledgments
The authors would like to thank all the athletes who participated in this investigation for their
enthusiasm and dedication to the project.
Author Contributions
Conceived and designed the experiments:MGDM-P CB-F.
Performed the experiments:MG BWDM-P CB-F PF.
Analyzed the data:MG.
Contributed reagents/materials/analysis tools:MG BWDM-P CB-F PF.
Wrote the paper:MG BWDM-P CB-F PF.
References
1. Burke LM, Desbrow B, Spriet L. Caffeine for Sports Performance. Champaign (IL): Human Kinetics;
2013.
2. Burke LM. Caffeine and sports performance. Appl Physiol Nutr Metab 2008; 33(6):1319–34. doi: 10.
1139/H08-130 PMID: 19088794
3. Graham TE. Caffeine and exercise. Sports Med 2001; 31(11):785–807. PMID: 11583104
4. Anderson ME, Bruce CR, Fraser SF, Stepto NK, Klein R, Hopkins WG, et al. Improved 2000-meter row-
ing performance in competitive oarswomen after caffeine ingestion. Int J Sport Nutr Exerc Metab 2000;
10(4):464–75. PMID: 11099373
5. Black CD, Waddell DE, Gonglach AR. Caffeine's ergogenic effects on cycling: neuromuscular and per-
ceptual factors. Med Sci Sports Exerc 2015; 47(6):1145–58. doi: 10.1249/MSS.0000000000000513
PMID: 25211364
6. Bridge CA, Jones MA. The effect of caffeine ingestion on 8 km run performance in a field setting. J
Sports Sci 2006; 24(4):433–9. PMID: 16492607
7. Bruce CR, Anderson ME, Fraser SF, Stepto NK, Klein R, Hopkins WG, et al. Enhancement of 2000-m
rowing performance after caffeine ingestion. Med Sci Sports Exerc 2000; 32(11):1958–63. PMID:
11079528
8. Glaister M, Pattison JR, Muniz-Pumares D, Patterson SD, Foley P. Effects of dietary nitrate, caffeine,
and their combination on 20 km cycling time-trial performance. J Strength Cond Res 2015; 29(1):165–
74. doi: 10.1519/JSC.0000000000000596 PMID: 24978834
Caffeine and Submaximal Exercise
PLOS ONE | DOI:10.1371/journal.pone.0161375 August 17, 2016 13 / 15
9. Hodgson AB, Randell RK, Jeukendrup AE. The metabolic and performance effects of caffeine com-
pared to coffee during endurance exercise. PLoS One 2013; 8(4):e59561. doi: 10.1371/journal.pone.
0059561 PMID: 23573201
10. Irwin C, Desbrow B, Ellis A, O'Keeffe B, Grant G, Leveritt M. Caffeine withdrawal and high-intensity
endurance cycling performance. J Sports Sci 2011; 29(5):509–15. doi: 10.1080/02640414.2010.
541480 PMID: 21279864
11. Kovacs EM, Stegen JH, Brouns F. Effect of caffeinated drinks on substrate metabolism, caffeine excre-
tion, and performance. J Appl Physiol 1998; 85(2):709–15. PMID: 9688750
12. MacIntosh BR,Wright BM. Caffeine ingestion and performance of a 1,500-metre swim. Can J Appl Phy-
siol 1995; 20(2):168–77. PMID: 7640644
13. Stadheim HK, Kvamme B, Olsen R, Drevon CA, Ivy JL, Jensen J. Caffeine increases performance in
cross-country double-poling time trial exercise. Med Sci Sports Exerc 2013; 45(11):2175–83. doi: 10.
1249/MSS.0b013e3182967948 PMID: 23591294
14. Stadheim HK, Spencer M, Olsen R, Jensen J. Caffeine and Performance over Consecutive Days of
Simulated Competition. Med Sci Sports Exerc 2014; 46(9):1787–96. doi: 10.1249/MSS.
0000000000000288 PMID: 25134002
15. Wiles JD, Bird SR, Hopkins J, Riley M. Effect of caffeinated coffee on running speed, respiratory fac-
tors, blood lactate and perceived exertion during 1500-m treadmill running. Br J Sports Med 1992; 26
(2):116–20. PMID: 1623356
16. Tarnopolsky MA. Effect of caffeine on the neuromuscular system-potential as an ergogenic aid. Appl
Physiol Nutr Metab 2008; 33(6):1284–9. doi: 10.1139/H08-121 PMID: 19088790
17. Kalmar JM. The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc 2005; 37
(12):2113–19. PMID: 16331138
18. Acker-Hewitt TL, Shafer BM, Saunders MJ, Goh Q, Luden ND. Independent and combined effects of
carbohydrate and caffeine ingestion on aerobic cycling performance in the fed state. Appl Physiol Nutr
Metab 2012; 37(2):276–83. doi: 10.1139/h11-160 PMID: 22436075
19. Dodd SL, Brooks E, Powers SK, Tulley R. The effects of caffeine on graded exercise performance in
caffeine naive versus habituated subjects. Eur J Appl Physiol Occup Physiol 1991; 62(6):424–9. PMID:
1893906
20. Tarnopolsky MA, Atkinson SA, MacDougall JD, Sale DG, Sutton JR. Physiological responses to caf-
feine during endurance running in habitual caffeine users. Med Sci Sports Exerc 1989; 21(4):418–24.
PMID: 2674593
21. Graham TE, Helge JW, MacLean DA, Kiens B, Richter EA. Caffeine ingestion does not alter carbohy-
drate or fat metabolism in human skeletal muscle during exercise. J Physiol 2000; 529(3):837–47.
22. Jenkins NT, Trilk JL, Singhal A, O'Connor PJ, Cureton KJ. Ergogenic effects of low doses of caffeine on
cycling performance. Int J Sport Nutr Exerc Metab 2008; 18(3):328–42. PMID: 18562777
23. Ryan EJ, Kim CH, Fickes EJ, Williamson M, Muller MD, Barkley JE, et al. Caffeine gum and cycling per-
formance: a timing study. J Strength Cond Res 2013; 27(1):259–64. doi: 10.1519/JSC.
0b013e3182541d03 PMID: 22476164
24. Skinner TL, Jenkins DG, Coombes JS, Taaffe DR, Leveritt MD. Dose response of caffeine on 2000-m
rowing performance. Med Sci Sports Exerc 2010; 42(3):571–6. doi: 10.1249/MSS.0b013e3181b6668b
PMID: 19952822
25. Jacobson TL, Febbraio MA, Arkinstall MJ, Hawley JA. Effect of caffeine co-ingested with carbohydrate
or fat on metabolism and performance in endurance-trained men. Exp Physiol 2001; 86(1):137–44.
PMID: 11429627
26. Simmonds MJ, Minahan CL, Sabapathy S. Caffeine improves supramaximal cycling but not the rate of
anaerobic energy release. Eur J Appl Physiol 2010; 109(2):287–95. doi: 10.1007/s00421-009-1351-8
PMID: 20082092
27. Bergman BC, Horning MA, Casazza GA, Wolfel EE, Butterfield GE, Brooks GA. Endurance training
increases gluconeogenesis during rest and exercise in men. Am Journal Physiol Endocrinol Metab
2000; 278(2):E244–51.
28. Koupenova M, Ravid K. Adenosine, adenosine receptors and their role in glucose homeostasis and
lipid metabolism. J Cell Physiol 2013; doi: 10.1002/jcp.24352
29. De Pauw K, Roelands B, Cheung SS, de Geus B, Rietjens G, Meeusen R. Guidelines to classify sub-
ject groups in sport-science research. Int J Sports Physiol Perform 2013; 8(2):111–22. PMID:
23428482
30. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold
thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32(1):77–
97. PMID: 4843734
Caffeine and Submaximal Exercise
PLOS ONE | DOI:10.1371/journal.pone.0161375 August 17, 2016 14 / 15
31. Vercruyssen F, Suriano R, Bishop D, Hausswirth C, Brisswalter J. Cadence selection affects metabolic
responses during cycling and subsequent running time to fatigue. Br J Sports Med 2005; 39(5):267–72.
PMID: 15849289
32. Borg G. Perceived exertion as an indicator of somatic stress. Scand J RehabMed 1970; 2(2):92–8.
33. Faude O, KindermannW, Meyer T. Lactate threshold concepts: how valid are they? Sports Med 2009;
39(6):469–90. doi: 10.2165/00007256-200939060-00003 PMID: 19453206
34. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas
exchange. J Appl Physiol 1986; 60(6):2020–7. PMID: 3087938
35. Newell J, Higgins D, Madden N, Cruickshank J, Einbeck J, McMillan K, et al. Software for calculating
blood lactate endurance markers. J Sports Sci 2007; 25(12):1403–9. PMID: 17786693
36. Graham TE, Battram DS, Dela F, El-Sohemy A, Thong FSL. Does caffeine alter muscle carbohydrate
and fat metabolism during exercise? Appl Physiol Nutr Metab 2008; 33(6):1311–18. doi: 10.1139/H08-
129 PMID: 19088793
37. Adamo KB, Graham TE. Comparison of traditional measurements with macroglycogen and proglyco-
gen analysis of muscle glycogen. J Appl Physiol 1998; 84(3):908–13. PMID: 9480951
38. Cheuvront SN, Ely BR, Kenefick RW, Michniak-Kohn BB, Rood JC, Sawka MN. No effect of nutritional
adenosine receptor antagonists on exercise performance in the heat. Am J Physiol Regul Integr Comp
Physiol 2009; 296(2):R394–401. doi: 10.1152/ajpregu.90812.2008 PMID: 19020291
39. Roelands B, Buyse L, Pauwels F, Delbeke F, Deventer K, Meeusen R. No effect of caffeine on exercise
performance in high ambient temperature. Eur J Appl Physiol 2011; 111(12):3089–95. doi: 10.1007/
s00421-011-1945-9 PMID: 21461761
40. Armstrong LE, Casa DJ, Maresh CM, Ganio MS. Caffeine, fluid-electrolyte balance, temperature regu-
lation, and exercise-heat tolerance. Exerc Sport Sci Rev 2007; 35(3):135–40. PMID: 17620932
41. Del Coso J, Estevez E, Mora-Rodriguez R. Caffeine during exercise in the heat: thermoregulation and
fluid-electrolyte balance. Med Sci Sports Exerc 2009; 41(1):164–73. doi: 10.1249/MSS.
0b013e318184f45e PMID: 19092693
42. Ganio MS, Johnson EC, Klau JF, Anderson JM, Casa DJ, Maresh CM, et al. Effect of ambient tempera-
ture on caffeine ergogenicity during endurance exercise. Eur J Appl Physiol 2011; 111(6):1135–46. doi:
10.1007/s00421-010-1734-x PMID: 21120518
43. Goedecke JH, St Clair Gibson A, Grobler L, Collins M, Noakes TD, Lambert EV. Determinants of the
variability in respiratory exchange ratio at rest and during exercise in trained athletes. Am J Physiol
Endocrinol Metab 2000; 279(6):E1325–34. PMID: 11093921
44. Howell LL, Coffin VL, Spealman RD. Behavioral and physiological effects of xanthenes in nonhuman
primates. Psychopharmacology 1997; 129(1):1–14. PMID: 9122357
45. McClaran SR, Wetter TJ. Low doses of caffeine reduce heart rate during submaximal cycle ergometry.
J Int Soc Sports Nutr 2007; 4(11).
46. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special ref-
erence to factors that contribute to its widespread use. Pharmacol Rev 1999; 51(1):83–133. PMID:
10049999
47. Rongen GA, Brooks SC, Pollard MJ, Ando S-I, Dajani HR, Notarius CF, et al. Effect of adenosine on
heart rate variability in humans. Clin Sci 1999; 96(6):597–604. PMID: 10334965
48. Doherty M, Smith PM. Effects of caffeine ingestion on rating of perceived exertion during and after exer-
cise: a meta-analysis. Scand J Med Sci Sports 2005; 15(2):69–78. PMID: 15773860
Caffeine and Submaximal Exercise
PLOS ONE | DOI:10.1371/journal.pone.0161375 August 17, 2016 15 / 15
